Docket #: S97-184
Monoclonal Antibody to Human CD81, 5A6
5A6 is monoclonal antibody (mAbs) which recognizes human CD81. It was identified by its ability to induce a reversible antiproliferative effect on a human lymphoma B cell line. This mAbs is capable of inducing signal signal transduction and cell adhesion. It is shown to bind to the large extracellular loop (EC2) of human CD81.
Applications
- Flow cytometric studies
- Immunoprecipitations
- Western blots
Advantages
- Most potent inducer of biological responses (i.e. antiproliferative effect, induction of homotypic adhesion, and inhibition of motility in lymphoid cells) compared to currently available CD81 mAbs.
- Excellent Western reagent
Publications
- "TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins." Oren R, Takahashi S, Doss C, Levy R, Levy S, Mol Cell Biol. 1990 Aug; 10(8): 4007-4015.
Similar Technologies
-
Blocking an immune receptor signal to treat obesity and fatty liver disease S23-015Blocking an immune receptor signal to treat obesity and fatty liver disease
-
Deriving Pure Compositions of Mammalian Megakaryocyte Progenitor Cells S02-234Deriving Pure Compositions of Mammalian Megakaryocyte Progenitor Cells
-
SMASh_CARs: A "drug off" chemogenetic system for regulating CAR T-cell therapy S17-501SMASh_CARs: A "drug off" chemogenetic system for regulating CAR T-cell therapy